- Home
- NXL vs IHT Comparison
NXL vs IHT Comparison
Compare NXL & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- IHT
- Stock Information
- Founded
- NXL 2010
- IHT 1971
- Country
- NXL United States
- IHT United States
- Employees
- NXL N/A
- IHT N/A
- Industry
- NXL Medical Specialities
- IHT Investment Bankers/Brokers/Service
- Sector
- NXL Health Care
- IHT Finance
- Exchange
- NXL Nasdaq
- IHT Nasdaq
- Market Cap
- NXL 21.0M
- IHT 19.0M
- IPO Year
- NXL 2022
- IHT N/A
- Fundamental
- Price
- NXL $1.12
- IHT $2.14
- Analyst Decision
- NXL Strong Buy
- IHT
- Analyst Count
- NXL 1
- IHT 0
- Target Price
- NXL $5.00
- IHT N/A
- AVG Volume (30 Days)
- NXL 116.3K
- IHT 1.9K
- Earning Date
- NXL 08-07-2025
- IHT 09-15-2025
- Dividend Yield
- NXL N/A
- IHT 0.93%
- EPS Growth
- NXL N/A
- IHT N/A
- EPS
- NXL N/A
- IHT N/A
- Revenue
- NXL $131,065.00
- IHT $7,505,309.00
- Revenue This Year
- NXL $79.59
- IHT N/A
- Revenue Next Year
- NXL $334.65
- IHT N/A
- P/E Ratio
- NXL N/A
- IHT N/A
- Revenue Growth
- NXL N/A
- IHT N/A
- 52 Week Low
- NXL $0.59
- IHT $1.34
- 52 Week High
- NXL $4.49
- IHT $2.70
- Technical
- Relative Strength Index (RSI)
- NXL 54.25
- IHT 41.45
- Support Level
- NXL $0.97
- IHT $2.14
- Resistance Level
- NXL $1.08
- IHT $2.35
- Average True Range (ATR)
- NXL 0.08
- IHT 0.07
- MACD
- NXL 0.03
- IHT -0.00
- Stochastic Oscillator
- NXL 70.00
- IHT 0.00
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.